Tenax Therapeutics, Inc. (TENX): Price and Financial Metrics

Tenax Therapeutics, Inc. (TENX): $1.96

-0.07 (-3.45%)

POWR Rating

Component Grades













TENX Stock Price Chart Interactive Chart >

Price chart for TENX

TENX Price/Volume Stats

Current price $1.96 52-week high $3.68
Prev. close $2.03 52-week low $0.80
Day low $1.96 Volume 38,301
Day high $2.03 Avg. volume 1,436,951
50-day MA $1.98 Dividend yield N/A
200-day MA $1.74 Market Cap 29.34M

Tenax Therapeutics, Inc. (TENX) Company Bio

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. The company was founded in 1967 and is based in Morrisville, North Carolina.

TENX Latest News Stream

Event/Time News Detail
Loading, please wait...

TENX Latest Social Stream

Loading social stream, please wait...

View Full TENX Social Stream

Latest TENX News From Around the Web

Below are the latest news stories about Tenax Therapeutics Inc that investors may wish to consider to help them evaluate TENX as an investment opportunity.

Hedge Funds Are Selling Tenax Therapeutics Inc (TENX)

In this article we will analyze whether Tenax Therapeutics Inc (NASDAQ:TENX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead […]

Yahoo | June 14, 2021

Tenax Therapeutics Set to Join Russell Microcap® Index

Tenax Therapeutics, Inc. (Nasdaq: TENX) announces inclusion in the Russell Microcap® Index after the U.S. market opens on June 28, 2021

Yahoo | June 10, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tenax Therapeutics, Inc - TENX

New York, New York--(Newsfile Corp. - June 7, 2021) - Levi & Korsinsky announces it has commenced an investigation of Tenax Therapeutics, Inc (NASDAQ: TENX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/tenax-therapeutics-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you.Levi & Korsinsky is a nat

Yahoo | June 7, 2021

Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update

Tenax Therapeutics, Inc. (Nasdaq: TENX) announces first quarter 2021 financial results and provides business update.

Yahoo | May 17, 2021

Tenax Rises on Progress With Hypertension Treatment

Tenax shares rose after the company reported progress in a Phase 2 study of levosimendan to treat pulmonary hypertension and heart failure.

Yahoo | April 9, 2021

Read More 'TENX' Stories Here

TENX Price Returns

1-mo 4.26%
3-mo -7.98%
6-mo 88.46%
1-year 76.58%
3-year -69.09%
5-year -96.34%
YTD 5.38%
2020 31.91%
2019 16.53%
2018 -87.65%
2017 -74.87%
2016 -40.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8913 seconds.